Related references
Note: Only part of the references are listed.Non-alcoholic fatty liver disease and insulin resistance: From bench to bedside
K. Gariani et al.
DIABETES & METABOLISM (2013)
Cellular Mechanism by Which Estradiol Protects Female Ovariectomized Mice From High-Fat Diet-Induced Hepatic and Muscle Insulin Resistance
Joao Paulo G. Camporez et al.
ENDOCRINOLOGY (2013)
CGI-58 knockdown sequesters diacylglycerols in lipid droplets/ER-preventing diacylglycerol-mediated hepatic insulin resistance
Jennifer L. Cantley et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Pleiotropic Actions of Insulin Resistance and Inflammation in Metabolic Homeostasis
Justin I. Odegaard et al.
SCIENCE (2013)
Diacylglycerol Activation of Protein Kinase Cε and Hepatic Insulin Resistance
Francois R. Jornayvaz et al.
CELL METABOLISM (2012)
Adiponectin: Key Player in the Adipose Tissue-Liver Crosstalk
A. R. Moschen et al.
CURRENT MEDICINAL CHEMISTRY (2012)
Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of randomised trials
G. Musso et al.
DIABETOLOGIA (2012)
Thyroid Hormone Receptor-α Gene Knockout Mice Are Protected from Diet-Induced Hepatic Insulin Resistance
Francois R. Jornayvaz et al.
ENDOCRINOLOGY (2012)
Dissociation of Inositol-requiring Enzyme (IRE1α)-mediated c-Jun N-terminal Kinase Activation from Hepatic Insulin Resistance in Conditional X-box-binding Protein-1 (XBP1) Knock-out Mice
Michael J. Jurczak et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Deletion of the Mammalian INDY Homo log Mimics Aspects of Dietary Restriction and Protects against Adiposity and Insulin Resistance in Mice
Andreas L. Birkenfeld et al.
CELL METABOLISM (2011)
Akt Stimulates Hepatic SREBP1c and Lipogenesis through Parallel mTORC1-Dependent and Independent Pathways
Jessica L. Yecies et al.
CELL METABOLISM (2011)
Pro-inflammatory and atherogenic circulating factors in non-alcoholic fatty liver disease associated to metabolic syndrome
Diego Lucero et al.
CLINICA CHIMICA ACTA (2011)
Changes in the Prevalence of the Most Common Causes of Chronic Liver Diseases in the United States From 1988 to 2008
Zobair M. Younossi et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2011)
Apolipoprotein CIII Overexpressing Mice Are Predisposed to Diet-Induced Hepatic Steatosis and Hepatic Insulin Resistance
Hui-Young Lee et al.
HEPATOLOGY (2011)
Influence of the Hepatic Eukaryotic Initiation Factor 2α (eIF2α) Endoplasmic Reticulum (ER) Stress Response Pathway on Insulin-mediated ER Stress and Hepatic and Peripheral Glucose Metabolism
Andreas L. Birkenfeld et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Ceramides as modulators of cellular and whole-body metabolism
Benjamin T. Bikman et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Inflammatory links between obesity and metabolic disease
Carey N. Lumeng et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin
William L. Holland et al.
NATURE MEDICINE (2011)
Hepatic insulin resistance in mice with hepatic overexpression of diacylglycerol acyltransferase 2
Francois R. Jornayvaz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
JNKs, insulin resistance and inflammation: A possible link between NAFLD and coronary artery disease
Giovanni Tarantino et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2011)
A high-fat, ketogenic diet causes hepatic insulin resistance in mice, despite increasing energy expenditure and preventing weight gain
Francois R. Jornayvaz et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2010)
The Effects of Salsalate on Glycemic Control in Patients With Type 2 Diabetes A Randomized Trial
Allison B. Goldfine et al.
ANNALS OF INTERNAL MEDICINE (2010)
The Role of Cytokines in Non-Alcoholic Fatty Liver Disease
Herbert Tilg
DIGESTIVE DISEASES (2010)
Standard operating procedures for describing and performing metabolic tests of glucose homeostasis in mice
Julio E. Ayala et al.
DISEASE MODELS & MECHANISMS (2010)
Nonobese Population in a Developing Country Has a High Prevalence of Nonalcoholic Fatty Liver and Significant Liver Disease
Kausik Das et al.
HEPATOLOGY (2010)
IL-6: from its discovery to clinical applications
Tadamitsu Kishimoto
INTERNATIONAL IMMUNOLOGY (2010)
Influence of polygenetic polymorphisms on the susceptibility to non-alcoholic fatty liver disease of Chinese people
Yong-Jian Zhou et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2010)
A position statement on NAFLD/NASH based on the EASL 2009 special conference
Vlad Ratziu et al.
JOURNAL OF HEPATOLOGY (2010)
Blockade of interleukin-6 signaling enhances hepatic steatosis but improves liver injury in methionine choline-deficient diet-fed mice
Kanji Yamaguchi et al.
LABORATORY INVESTIGATION (2010)
mTORC1 activates SREBP-1c and uncouples lipogenesis from gluconeogenesis
Mathieu Laplante et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Hepatic steatosis, low-grade chronic inflammation and hormone/growth factor/adipokine imbalance
Giovanni Tarantino et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2010)
Harmonizing the Metabolic Syndrome A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity
K. G. M. M. Alberti et al.
CIRCULATION (2009)
Cellular mechanisms of insulin resistance: role of stress-regulated serine kinases and insulin receptor substrates (IRS) serine phosphorylation
Jean-Francois Tanti et al.
CURRENT OPINION IN PHARMACOLOGY (2009)
Adipokines in Liver Diseases
Fabio Marra et al.
HEPATOLOGY (2009)
Diagnostic value of a group of biochemical markers of liver fibrosis in patients with non-alcoholic steatohepatitis
C. Rinaldi A. Lesmana et al.
JOURNAL OF DIGESTIVE DISEASES (2009)
Increased hepatic and circulating interleukin-6 levels in human nonalcoholic steatohepatitis
Anna Wieckowska et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
Identification and characterization of metabolically benign obesity in humans
Norbert Stefan et al.
ARCHIVES OF INTERNAL MEDICINE (2008)
Adipose macrophage infiltration is associated with insulin resistance and vascular endothelial dysfunction in obese subjects
Caroline M. Apovian et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
IRS1-independent defects define major nodes of insulin resistance
Kyle L. Hoehn et al.
CELL METABOLISM (2008)
Selective versus total insulin resistance: A pathogenic paradox
Michael S. Brown et al.
CELL METABOLISM (2008)
Hepatic triglyceride synthesis and nonalcoholic fatty liver disease
Steve S. Choi et al.
CURRENT OPINION IN LIPIDOLOGY (2008)
The Adipocyte as an Endocrine Cell
Nils Halberg et al.
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2008)
Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes
Anna Kotronen et al.
GASTROENTEROLOGY (2008)
A randomized controlled pilot study of Pentoxifylline in patients with non-alcoholic steatohepatitis (NASH)
Yin-Mei Lee et al.
HEPATOLOGY INTERNATIONAL (2008)
Insulin sensitivity: modulation by nutrients and inflammation
Simon Schenk et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Interleukin-10 is a protective factor against diet-induced insulin resistance in liver
Dennys E. Cintra et al.
JOURNAL OF HEPATOLOGY (2008)
Ceramide is a cardiotoxin in lipotoxic cardiomyopathy
Tae-Sik Park et al.
JOURNAL OF LIPID RESEARCH (2008)
Effect of weight loss on some serum cytokines in human obesity: increase in IL-10 after weight loss
Sun Hye Jung et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2008)
Cause-specific excess deaths associated with underweight, overweight, and obesity
Katherine M. Flegal et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Suppression of diacylglycerol acyltransferase-2 (DGAT2), but not DGAT1, with antisense oligonucleotides reverses diet-induced hepatic steatosis and insulin resistance
Cheol Soo Choi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Dissociation of hepatic steatosis and insulin resistance in mice overexpressing DGAT in the liver
Mara Monetti et al.
CELL METABOLISM (2007)
How common is non-alcoholic fatty liver disease in the Asia-Pacific region and are there local differences?
Deepak N. Amarapurkar et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2007)
Functional studies of Akt isoform specificity in skeletal muscle in vivo; Maintained insulin sensitivity despite reduced insulin receptor substrate-1 expression
Mark E. Cleasby et al.
MOLECULAR ENDOCRINOLOGY (2007)
Endogenous interleukin-10 protects against hepatic steatosis but does not improve insulin sensitivity during high-fat feeding in mice
Marion A. M. den Boer et al.
ENDOCRINOLOGY (2006)
Signalling mechanisms linking hepatic glucose and lipid metabolism
M. O. Weickert et al.
DIABETOLOGIA (2006)
Inflammation and insulin resistance
Steven E. Shoelson et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Etiology of insulin resistance
KF Petersen et al.
AMERICAN JOURNAL OF MEDICINE (2006)
Reversal of diet-induced hepatic steatosis and hepatic insulin resistance by antisense oligonucleotide inhibitors of acetyl-CoA carboxylases 1 and 2
DB Savage et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Mature-onset obesity and insulin resistance in mice deficient in the signaling adapter p62
A Rodriguez et al.
CELL METABOLISM (2006)
Insulin resistance: A metabolic pathway to chronic liver disease
E Bugianesi et al.
HEPATOLOGY (2005)
Antisense oligonucleotide reduction of DGAT2 expression improves hepatic steatosis and hyperlipidemia in obese mice
XX Yu et al.
HEPATOLOGY (2005)
Increased p85/55/50 expression and decreased phosphotidylinositol 3-kinase activity in insulin-resistant human skeletal muscle
GK Bandyopadhyay et al.
DIABETES (2005)
The natural history of nonalcoholic fatty liver disease: A population-based cohort study
LA Adams et al.
GASTROENTEROLOGY (2005)
Inflammation, stress, and diabetes
KE Wellen et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease
KL Donnelly et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms
E Bugianesi et al.
DIABETOLOGIA (2005)
Reversal of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycemia by moderate weight reduction in patients with type 2 diabetes
KF Petersen et al.
DIABETES (2005)
Cytokines and the pathogenesis of non-alcoholic steatohepatitis
AM Diehl et al.
GUT (2005)
Non-alcoholic fatty liver disease in young adult severely obese non-diabetic patients in South Italy
P Colicchio et al.
ANNALS OF NUTRITION AND METABOLISM (2005)
Hepatic expression of malonyl-CoA decarboxylase reverses muscle, liver and whole-animal insulin resistance
J An et al.
NATURE MEDICINE (2004)
Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease
VT Samuel et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Beyond insulin resistance in NASH:: TNF-α or adiponectin?
JM Hui et al.
HEPATOLOGY (2004)
Suppressor of cytokine signaling 1 (SOCS-1) and SOCS-3 cause insulin resistance through inhibition of tyrosine phosphorylation of insulin receptor substrate proteins by discrete mechanisms
K Ueki et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Adiponectin induces the anti-inflammatory cytokines IL-10 and IL-1RA in human leukocytes
AM Wolf et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Adiponectin specifically increased tissue inhibitor of metalloproteinase-1 through interleukin-10 expression in human macrophages
M Kumada et al.
CIRCULATION (2004)
Cycloserine and threo-dihydrosphingosine inhibit TNF-α-induced cytotoxicity:: evidence for the importance of de novo ceramide synthesis in TNF-α-signaling
SGE Meyer et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2003)
Inflammatory pathways and insulin action
GS Hotamisligil
INTERNATIONAL JOURNAL OF OBESITY (2003)
Regulation of adiponectin by adipose tissue-derived cytokines: in vivo and in vitro investigations in humans
JM Bruun et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2003)
Adiponectin expression from human adipose tissue -: Relation to obesity, insulin resistance, and tumor necrosis factor-α expression
PA Kern et al.
DIABETES (2003)
The adipocyte in insulin resistance: key molecules and the impact of the thiazolidinediones
P Arner
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2003)
Association between adiponectin and mediators of inflammation in obese women
S Engeli et al.
DIABETES (2003)
Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IκB-α
SI Itani et al.
DIABETES (2002)
Altered tumor necrosis factor-α (TNF-α) processing in adipocytes and increased expression of transmembrane TNF-α in obesity
HY Xu et al.
DIABETES (2002)
Free fatty acids in obesity and type 2 diabetes:: defining their role in the development of insulin resistance and β-cell dysfunction
G Boden et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2002)
Adipose tissue IL-6 content correlates with resistance to insulin activation of glucose uptake both in vivo and in vitro
JP Bastard et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2002)
Interleukin-6-deficient mice develop mature-onset obesity
V Wallenius et al.
NATURE MEDICINE (2002)
Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin
WS Yang et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2001)
Nonalcoholic fatty liver disease - A feature of the metabolic syndrome
G Marchesini et al.
DIABETES (2001)
Tissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin resistance
JK Kim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Mechanisms of disease: Cytokines in alcoholic and nonalcoholic steatohepatitis.
H Tilg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients
K Hotta et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2000)
Prolonged elevation of plasma free fatty acids impairs pancreatic β-cell function in obese nondiabetic humans but not in individuals with type 2 diabetes
A Carpentier et al.
DIABETES (2000)
Share Paper
